Choreo LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Choreo LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.75M	Sell	6,166 -842	-12%	-$393K	0.03%	322
2025 Q4	$3.18M	Buy	7,008 +1,154	+20%	+$497K	0.04%	270
2025 Q3	$2.29M	Sell	5,854 -499	-8%	-$209K	0.03%	344
2025 Q2	$2.83M	Sell	6,353 -40	-0.6%	-$18.4K	0.04%	286
2025 Q1	$3.1M	Buy	6,393 +301	+5%	+$140K	0.05%	256
2024 Q4	$2.43M	Buy	6,092 +154	+3%	+$71.4K	0.04%	306
2024 Q3	$2.79M	Buy	5,938 +1,590	+37%	+$764K	0.04%	281
2024 Q2	$2.05M	Buy	4,348 +3,858	+787%	+$1.67M	0.03%	315
2024 Q1	$205K	Buy	+490	New	+$207K	0.01%	625

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Choreo LLC's VRTX Position: Q1 2026 in Review

Choreo LLC reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, selling an estimated $393K and leaving 6,166 shares worth $2.75M. The position accounts for 0.03% of the portfolio, ranked #322.

Choreo LLC first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.18M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Choreo LLC held 6,166 shares of Vertex Pharmaceuticals worth $2.75M as of Q1 2026.
Choreo LLC sold 842 Vertex Pharmaceuticals shares in Q1 2026, an estimated $393K.
Vertex Pharmaceuticals made up 0.03% of Choreo LLC's portfolio in Q1 2026, its #322 holding.
Choreo LLC first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Choreo LLC's Vertex Pharmaceuticals position peaked at $3.18M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.